CR Double-Crane
60006216.270.25% ( +0.04 )
CR Double-Crane (600062)
China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical p...
- Open
- 16.04
- High
- 16.27
- Low
- 16.02
- Prev. Close
- 16.23
- Volume
- 133.70K
- Turnover
- 215.87M
- Avg Price
- 16.15
- Bid/Ask Ratio
- --
- Amplitude
- 1.54%
- 52wk High
- 21.66
- Volume Ratio
- 0.94
- Turnover Ratio
- 1.29%
CR Double-Crane Analyst Rating
View MoreForecast & Rating
May 21, 2026Price forecast
¥25.3255.65%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 1 day ago, 05:37 PM
China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier Chemical
- PUBT · Jul 15 at 09:12 AM
China Resources Pharma unit tops bid to buy 23.5% stake in Lier Chemical
- AASTOCKS · Apr 19 at 11:08 PM
CHINARES PHARMA introduces new product system for downstream customers under 1,4-Butanediamine
- Wallstreetcn · Feb 28 at 06:02 AM
Han Song, Deputy General Manager of China Resources Group, is under investigation
- Zhitong · Oct 29, 2025 at 04:51 AM
CR Double-Crane: Some drugs are proposed to be selected for national centralized drug procurement
- Zhitong · Oct 24, 2025 at 04:18 AM
CR Pharmaceutical: CR Double-Crane's net profit for the first three quarters is 1.388 billion yuan, a year-on-year decrease of 1.7%
